Light Drizzle Fog/Mist 44°
Tag:

BioNTech

News
Pfizer Asks FDA To Approve Emergency Use Of COVID Vaccine In Kids 12-15 Pfizer Asks FDA To Approve Emergency Use Of COVID Vaccine In Kids 12-15
Pfizer Asks FDA To Approve Emergency Use Of COVID Vaccine In Kids 12-15 Pfizer and BioNTech on Friday asked the Food and Drug Administration to expand emergency use authorization of the COVID-19 vaccine to include children ages 12 to 15. The request comes following the Phase 3 trial in children ages 12 to 15, which demonstrated 100 percent efficacy and robust antibody response after vaccination. The companies plan to request similar rulings by other regulatory authorities worldwide in coming days. "The hope of starting to vaccinate this age group before the start of the next school year," CEO Albert Bourla previously said in a statement. According t…

SHARE

by Cecilia Levine
News
COVID-19: Pfizer Boasts Vaccine Candidate That's More Than 90% Effective COVID-19: Pfizer Boasts Vaccine Candidate That's More Than 90% Effective
Covid-19: Pfizer Boasts Vaccine Candidate That's More Than 90% Effective More reliable than the flu shot? Pfizer on Monday trumpeted a COVID-19 vaccine candidate as more than 90% effective – nearly three times better than the effectiveness of last season’s influenza vaccine. Pfizer said it hopes to have 50 million doses of the free vaccine ready by the end of this year and as many as 1.3 billion doses available next year to fight the deadly global pandemic. Two doses per person of BNT162b2 would be necessary, said the Manhattan-based drug maker, which teamed up with BioNTech of Germany to develop the booster. Pfizer plans to ask the federal Food and Drug Admini…

SHARE

by Jerry DeMarco